Ab­b­Vie and In­cyte re­port PhI­Ib vi­tili­go da­ta on oral JAKs an­a­lysts call ‘un­dif­fer­en­ti­at­ed’

Ab­b­Vie and In­cyte pre­sent­ed pos­i­tive Phase IIb re­sults of their re­spec­tive oral JAK in­hibitors in non-seg­men­tal vi­tili­go (NSV) at the Eu­ro­pean Acad­e­my of Der­ma­tol­ogy and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER